EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England

Oliver Eales iD, David Haw, Haowei Wang, Christina Atchison, Deborah Ashby, Graham S Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Christl A Donnelly, Marc Chadeau-Hyam, Paul Elliott und 1 weitere

PLOS Biology · 2023

DOI: 10.1371/journal.pbio.3002118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Oliver Eales und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The relationship between prevalence of infection and severe outcomes such as hospitalisation and death changed over the course of the COVID-19 pandemic. Reliable estimates of the infection fatality ratio (IFR) and infection hospitalisation ratio (IHR) along with the time-delay between infection and hospitalisation/death can inform forecasts of the numbers/timing of severe outcomes and allow healthcare services to better prepare for periods of increased demand. The REal-time Assessment of Community Transmission-1 (REACT-1) study estimated swab positivity for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in England approximately monthly from May 2020 to March 2022. Here, we analyse the changing relationship between prevalence of swab positivity and the IFR and IHR over this period in England, using publicly available data for the daily number of deaths and hospitalisations, REACT-1 swab positivity data, time-delay models, and Bayesian P-spline models. We analyse data for all age groups together, as well as in 2 subgroups: those aged 65 and over and those aged 64 and under. Additionally, we analysed the relationship between swab positivity and daily case numbers to estimate the case ascertainment rate of England’s mass testing programme. During 2020, we estimated the IFR to be 0.67% and the IHR to be 2.6%. By late 2021/early 2022, the IFR and IHR had both decreased to 0.097% and 0.76%, respectively. The average case ascertainment rate over the entire duration of the study was estimated to be 36.1%, but there was some significant variation in continuous estimates of the case ascertainment rate. Continuous estimates of the IFR and IHR of the virus were observed to increase during the periods of Alpha and Delta’s emergence. During periods of vaccination rollout, and the emergence of the Omicron variant, the IFR and IHR decreased. During 2020, we estimated a time-lag of 19 days between hospitalisation and swab positivity, and 26 days between deaths and swab positivity. By late 2021/early 2022, these time-lags had decreased to 7 days for hospitalisations and 18 days for deaths. Even though many populations have high levels of immunity to SARS-CoV-2 from vaccination and natural infection, waning of immunity and variant emergence will continue to be an upwards pressure on the IHR and IFR. As investments in community surveillance of SARS-CoV-2 infection are scaled back, alternative methods are required to accurately track the ever-changing relationship between infection, hospitalisation, and death and hence provide vital information for healthcare provision and utilisation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Bayes TheoremPandemicsEnglandHospitalization

Autor:innen und Institutionen

  • School of Public Health, Imperial College London, London, United Kingdom.
  • MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, United Kingdom.
  • Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Imperial College Healthcare NHS Trust, London, United Kingdom.
  • National Institute for Health Research Imperial Biomedical Research Centre, London, United Kingdom.
  • Institute of Global Health Innovation, Imperial College London, London, United Kingdom.

ORCID-Profile: Oliver Eales

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Cancer Research UK
  • Department of Health
  • British Heart Foundation
  • Department of Health and Social Care
  • National Institute for Health Research
  • Centres for Disease Control and Prevention

Zitieren

APA

Eales, O., Haw, D., Wang, H., Atchison, C., Ashby, D., Cooke, G. S., Barclay, W., Ward, H., Darzi, A., Donnelly, C. A., Chadeau-Hyam, M., Elliott, P., & Riley, S. (2023). Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002118

Vancouver

Eales O, Haw D, Wang H, Atchison C, Ashby D, Cooke GS, et al. Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002118

BibTeX
@article{Eales2023,
  author = {Eales, Oliver and Haw, David and Wang, Haowei and Atchison, Christina and Ashby, Deborah and Cooke, Graham S and Barclay, Wendy and Ward, Helen and Darzi, Ara and Donnelly, Christl A and Chadeau-Hyam, Marc and Elliott, Paul and Riley, Steven},
  title = {Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England},
  journal = {PLOS Biology},
  year = {2023},
  doi = {10.1371/journal.pbio.3002118}
}
Kostenlos starten →